| 1 | Peptides in cosmeceuticals (10.30978/ujdvk2019-1-28) | Abstract References ORCID License | 77.82 | 5 |
| 2 | Influence of complex therapy on indicators of markers of oxi… (10.30978/ujdvk2019-2-45) | Abstract References ORCID License | 69.90 | 4 |
| 3 | Analytical review of incidence rate for sexually transmitted… (10.30978/ujdvk2018-3-15) | Abstract References ORCID License | 60.21 | 3 |
| 4 | Atopic dermatitis and eczema: emergency care and effective t… (10.30978/ujdvk2019-3-58) | Abstract References ORCID License | 60.21 | 3 |
| 5 | Modern complex treatment of microsporia of the scalp in chil… (10.30978/ujdvk2019-1-65) | Abstract References ORCID License | 47.71 | 2 |
| 6 | Melanogenesis — an update (10.30978/ujdvk2021-1-58) | References ORCID License | 35.78 | 2 |
| 7 | Optimization of treatment and prognosis of acute and chronic… (10.30978/ujdvk2021-2-10) | References ORCID License | 35.78 | 2 |
| 8 | Pathogenetic therapy of patients with acne, taking into acco… (10.30978/ujdvk2022-1-2-5) | References ORCID License | 35.78 | 2 |
| 9 | Energetic capabilities of peripheral blood cells and their c… (10.30978/ujdvk2018-1-61) | Abstract References ORCID License | 30.10 | 1 |
| 10 | How oral collagen intake can be useful in dermatology (10.30978/ujdvk2018-1-99) | Abstract References ORCID License | 30.10 | 1 |
| 11 | 15th Spring Symposium of the European Academy of Dermatology… (10.30978/ujdvk2018-2-114) | Abstract References ORCID License | 30.10 | 1 |
| 12 | Indices of lipid metabolism in patients with psoriasis of au… (10.30978/ujdvk2018-2-25) | Abstract References ORCID License | 30.10 | 1 |
| 13 | Quality of life in acne patients with Demodex folliculorum a… (10.30978/ujdvk2018-2-38) | Abstract References ORCID License | 30.10 | 1 |
| 14 | Onychodistrophy in skin diseases and complex therapy with t… (10.30978/ujdvk2018-2-43) | Abstract References ORCID License | 30.10 | 1 |
| 15 | AEvit in complex treatment of acne patients (10.30978/ujdvk2018-2-48) | Abstract References ORCID License | 30.10 | 1 |
| 16 | Cutaneous side effects of oncology treatments. Part I. Chemo… (10.30978/ujdvk2018-3-62) | Abstract References ORCID License | 30.10 | 1 |
| 17 | Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse… (10.30978/ujdvk2018-3-81) | Abstract References ORCID License | 30.10 | 1 |
| 18 | Modern view on treatment of microsporia of children, taking… (10.30978/ujdvk2018-4-16) | Abstract References ORCID License | 30.10 | 1 |
| 19 | Retinoids-phobia — main aspects of the problem and facts of… (10.30978/ujdvk2018-4-57) | Abstract References ORCID License | 30.10 | 1 |
| 20 | Cutaneous side effects of oncology treatmentsPart II. Radiat… (10.30978/ujdvk2018-4-70) | Abstract References ORCID License | 30.10 | 1 |
| 21 | Acariases. Clinical cases from practice (10.30978/ujdvk2019-1-109) | Abstract References ORCID License | 30.10 | 1 |
| 22 | Investigation of the impact of Prostrolane Natural-B on the… (10.30978/ujdvk2019-1-21) | Abstract References ORCID License | 30.10 | 1 |
| 23 | Modern complex treatment of microsporia (10.30978/ujdvk2019-2-37) | Abstract References ORCID License | 30.10 | 1 |
| 24 | New opportunities of external antibacterial therapy (10.30978/ujdvk2019-2-63) | Abstract References ORCID License | 30.10 | 1 |
| 25 | Role of chronic stress, state and trait anxiety and certain… (10.30978/ujdvk2019-2-7) | Abstract References ORCID License | 30.10 | 1 |
| 26 | Onychomycosis: modern possibilities of topical therapy (10.30978/ujdvk2019-2-88) | Abstract References ORCID License | 30.10 | 1 |
| 27 | Lipid metabolism in skin of patients with psoriasis and pros… (10.30978/ujdvk2019-2-93) | Abstract References ORCID License | 30.10 | 1 |
| 28 | Justification of antibacterial therapy for atopic dermatitis (10.30978/ujdvk2019-3-83) | Abstract References ORCID License | 30.10 | 1 |
| 29 | «Chaos and Clues» algorithm in routine practice of analyzing… (10.30978/ujdvk2019-4-65) | Abstract References ORCID License | 30.10 | 1 |
| 30 | Modern approaches to treatment of chronic spontaneous urtica… (10.30978/ujdvk2020-2-34) | Abstract References ORCID License | 30.10 | 1 |
| 31 | Dermocosmetics as integral component in management of patien… (10.30978/ujdvk2020-2-41) | Abstract References ORCID License | 30.10 | 1 |
| 32 | Dermatoscopic and morphological features of some clinical va… (10.30978/ujdvk2020-3-69) | Abstract References ORCID License | 30.10 | 1 |
| 33 | Prospects of screening skin neoplasms in servicemen of the A… (10.30978/ujdvk2020-3-93) | Abstract References ORCID License | 30.10 | 1 |
| 34 | Gottron’s carcinoid papillomatosis of skin (features of clin… (10.30978/ujdvk2021-1-15) | References ORCID License | 22.58 | 1 |
| 35 | Study of clinical features of patients with chronic eczema (10.30978/ujdvk2021-4-23) | References ORCID License | 22.58 | 1 |
| 36 | Photoprotection: new concepts, controversies and trends in 2… (10.30978/ujdvk2022-1-2-47) | References ORCID License | 22.58 | 1 |
| 37 | All-Ukrainian scientific and practical conference with inte… (10.30978/ujdvk2023-4-63) | Abstract References ORCID | 22.58 | 1 |
| 38 | Psoriatic onychodystrophy — modern treatment trends (10.30978/ujdvk2021-2-43) | References License | 15.05 | 1 |
| 39 | Relationships between psoriasis severity indices and dermato… (10.30978/ujdvk2021-3-11) | References License | 15.05 | 1 |
| 40 | A саsе of effective treatment of acne in patient with secon… (10.30978/ujdvk2021-3-27) | References License | 15.05 | 1 |
| 41 | Analysis of molecular mechanisms of development of actinic k… (10.30978/ujdvk2021-3-66) | References License | 15.05 | 1 |
| 42 | The effectiveness of nonhormonal cream Solivin™ in combinat… (10.30978/ujdvk2022-1-2-31) | References License | 15.05 | 1 |
| 43 | Testing of some cosmetic and hygiene products of the CHOICE… (10.30978/ujdvk2022-1-2-36) | References License | 15.05 | 1 |
| 44 | Psorias: current status of incidence and organizational meas… (10.30978/ujdvk2022-3-4-42) | References | 11.93 | 2 |
| 45 | Seborrheic dermatitis: unique possibilities of vitamin thera… (10.30978/ujdvk2023-2-18) | References | 7.53 | 1 |
| 46 | Pyogenic granuloma — hypotheses of etiopathogenesis, clinic… (10.30978/ujdvk2023-2-4) | References | 7.53 | 1 |
| 47 | Analysis of factors complicating the course of acne (10.30978/ujdvk2023-3-19) | References | 7.53 | 1 |
| 48 | Miescher’s cheilitis granulomatosa: a case report (10.30978/ujdvk2024-1-30) | References | 7.53 | 1 |
| 49 | Topical retinoids: role and place in acne therapy (10.30978/ujdvk2024-1-34) | References | 7.53 | 1 |
| 50 | Use of antimicrobial peptides to eliminate immunodeficiency… (10.30978/ujdvk2024-3-13) | References | 7.53 | 1 |